Showing results (691-700 of 875) with videos related to

Sort By:
Pageof 88
Neurology|August 2, 2022
Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple SclerosisGabriel Bsteh, Nik Krajnc, Katharina Riedl, et al.
Behaviour Research and Therapy|August 12, 2017
Time to remission from mild to moderate depressive symptoms: One year results from the EVIDENT-study, an RCT of an internet intervention for depressionJan Philipp Klein, Christina Späth, Johanna Schröder, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2022
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosisKlaus Berek, Harald Hegen, Jakob Hocher, et al.
International Journal of Environmental Research and Public Health|December 11, 2022
High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with COVID-19 Vaccine Breakthrough InfectionMatthias Wolfgang Heinzl, Lisa Kolenchery, Michael Resl, et al.
Brain and Behavior|November 18, 2024
Neurofilament Light Chain Is Associated With Acute Mountain SicknessKlaus Berek, Anna Lindner, Franziska Di Pauli, et al.
Multiple Sclerosis and Related Disorders|December 11, 2024
Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosisGabriel Bsteh, Stefanie Marti, Nik Krajnc, et al.
BMC Geriatrics|December 10, 2024
Tailored internet-delivered cognitive behavior therapy for depression in older adults: a randomized controlled trialLise Bergman Nordgren, Mikael Ludvigsson, Kristin Silfvernagel, et al.
Bioactive Materials|September 22, 2023
Silver-integrated EDM processing of TiAl6V4 implant material has antibacterial capacity while optimizing osseointegrationHilmar Büssemaker, Ann-Kathrin Meinshausen, Viet Duc Bui, et al.
European Journal of Neurology|March 18, 2021
Retinal layer thinning predicts treatment failure in relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
JMIR Research Protocols|May 7, 2021
The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot StudyPatrick Altmann, Werner Hinterberger, Fritz Leutmezer, et al.
Pageof 88